. Author manuscript; available in PMC: 2016 Mar 1.

Published in final edited form as: Transfusion. 2014 Oct 14;55(3):674–679. doi: 10.1111/trf.12881

Table 1.

Cell product types manufactured for clinical use and total number of product administration data forms collected.

A subset of the total number of administrations by each cell product type occurring since 2010, during which the request for outcome data collection began, is indentified in the table.

Cell Product Type	Product Administration Forms (2003-2014)	Product Administration Forms (2010-2014)^*	Post-Product Administration (Outcome) Data Forms
Cell Product Type	Product Administration Forms (2003-2014)	Product Administration Forms (2010-2014)^*	Month 3	Month 6	Month 12
Bone marrow mononuclear cells (BM-MNCs)	240	141	26	25	23
Cytotoxic T lymphocytes (CTLs)	209	132	9	8	1
Natural killer (NK) cells	77	15	13	6	1
Dendritic cells (DCs)	49	0	0	0	0
T regulatory cells (Tregs)	46	5	3	1	0
Hematopoietic stem cells (HSCs)	29	29	29	23	21
Mesenchymal stem/stromal cells (MSCs)	13	13	10	2	0
CD133⁺ progenitor cells	2	2	0	0	0
Total forms collected	665	337	90	65	46

Outcome data collection began in 2010